NasdaqGM - Nasdaq Real Time Price USD

Disc Medicine, Inc. (IRON)

Compare
64.89 +0.62 (+0.96%)
At close: December 13 at 4:00:02 PM EST
64.89 0.00 (0.00%)
After hours: December 13 at 5:19:13 PM EST
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for IRON

Recent News: IRON

View More
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire 6 days ago
Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting

Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire 6 days ago
Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks

Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
TipRanks 21 days ago
Disc Medicine to Participate in Upcoming Investor Conferences

Disc Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire last month
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update

Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire last month
Disc Medicine secures $200m financing to support trials

Disc Medicine secures $200m financing to support trials
Clinical Trials Arena last month
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
GlobeNewswire last month
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire last month
Disc teases potential NDA for rare skin disorder drug

Disc teases potential NDA for rare skin disorder drug
Pharmaceutical Technology last month
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval

Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval
GlobeNewswire last month
Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
GlobeNewswire last month
View More

Related Tickers

MURA Mural Oncology plc
3.6400
-2.67%
 
APGE Apogee Therapeutics, Inc.
44.50
+0.41%
 
ELVN Enliven Therapeutics, Inc.
23.15
+0.65%
 
EWTX Edgewise Therapeutics, Inc.
27.62
-1.88%
 
SYRE Spyre Therapeutics, Inc.
24.12
+0.84%
 
PTGX Protagonist Therapeutics, Inc.
41.08
+1.73%
 
COGT Cogent Biosciences, Inc.
8.15
-2.28%
 
CNTA Centessa Pharmaceuticals plc
16.57
-1.78%
 
NUVL Nuvalent, Inc.
86.86
+0.05%
 
MLTX MoonLake Immunotherapeutics
51.34
-4.52%